...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Radiology >Ambulatory sclerotherapy for malignant pleural effusions.
【24h】

Ambulatory sclerotherapy for malignant pleural effusions.

机译：动态硬化疗法治疗恶性胸腔积液。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

PURPOSE: To determine the feasibility of ambulatory drainage and sclerotherapy in malignant pleural effusions. MATERIALS AND METHODS: Nineteen consecutive patients with symptomatic malignant pleural effusions were enrolled. None of the patients previously underwent sclerotherapy. A fluoroscopically placed 10.3-F catheter was connected to a closed gravity drainage bag system. Sclerotherapy was performed with bleomycin when daily drainage was less than 100 mL. Radiographic response was graded at 30 days. All patients were examined for symptomatic response and for complications. RESULTS: The tubes remained in place 2-11 days (mean, 5.1 days). Total pleural drainage ranged from 950 to 3,925 mL (mean, 1,647 mL); all 19 patients had improvement of symptoms. At 30 days, 10 (53%) patients had a complete response, five (26%) had a partial response, and four (21%) had progressive disease. CONCLUSION: Ambulatory sclerotherapy is a safe, viable alternative to conventional inpatient treatment of malignant pleural effusions.
机译：目的：确定动态引流和硬化治疗恶性胸腔积液的可行性。材料与方法：纳入19例有症状的恶性胸腔积液患者。以前没有患者接受硬化疗法。荧光镜下放置的10.3-F导管连接到封闭的重力引流袋系统。当每日引流少于100 mL时，用博来霉素进行硬化治疗。放射线反应评分为30天。检查所有患者的症状反应和并发症。结果：试管保留在原位2-11天（平均5.1天）。胸膜总引流范围为950至3,925 mL（平均1,647 mL）;所有19例患者的症状均有改善。在第30天，有10名患者（53％）完全缓解，五名患者（26％）部分缓解，四名患者（21％）患有进展性疾病。结论：动态硬化疗法是常规住院恶性胸腔积液治疗的安全，可行的替代方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号